ROVALCYTE 450 mg, film-coated tablet 60 tablets
Active ingredients: Valganciclovir hydrochloride, Valganciclovir
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet60 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ROVALCYTE 450 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) de 60 comprimé(s) avec fermeture de sécurité enfant
- Marketing authorisation holder
- CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Feb 2003
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62962307CIP73601361CIP133400936013612Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VALGANCICLOVIRcomprimé | 450 mg · un comprimé | FT |
| CHLORHYDRATE DE VALGANCICLOVIRcomprimé | 496,30 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.